Elizabeth Holmes' Husband Billy Evans Reveals His New Biotech Startup

Billy Evans, husband of convicted Theranos founder Elizabeth Holmes, has spoken publicly about their relationship, her prison sentence, and his new biotech company.

In a candid interview, Evans also addressed accusations that he's building “Theranos 2.0.”

How Billy Evans Met Elizabeth Holmes

Evans met Holmes in October 2017 at a San Francisco party, when Theranos was already facing intense scrutiny.

They became friends before starting a relationship approximately six months later.

Just weeks after they began dating, Holmes was indicted on federal fraud charges.

Evans says he believed in her innocence throughout the trial and continues to support her.

Elizabeth Holmes' Prison Sentence

Holmes was convicted of three investor fraud counts and one conspiracy count related to Theranos.

She received a sentence of 11 years and three months, along with a substantial restitution obligation.

Evans discussed the difficulties of raising their two children while Holmes serves her sentence at a federal prison camp in Texas.

He also challenged aspects of the prosecution's case, although his account represents his personal perspective rather than a reversal of the convictions.

Billy Evans' New Company: Hemanthes

Evans is now building a biotechnology company called Hemanthes.

The startup focuses on developing affordable sensors that can analyze biological samples using Raman spectroscopy.

The technology works by shining light through samples and analyzing how the light scatters to identify chemical structures.

Evans wants to make this technology smaller, cheaper, and more accessible.

Why AI Is Central to the Business

Unlike traditional diagnostic devices designed primarily for doctors, Evans wants Hemanthes to produce detailed biological datasets that artificial intelligence can analyze.

His vision includes:

• Making expensive laboratory sensors more affordable.

• Collecting richer biological data.

• Using AI to identify patterns across biological signals.

• Expanding access to advanced sensing technology.

Evans says his experience at autonomous vehicle technology company Luminar helped prepare him for this work.

Is Hemanthes Really Theranos 2.0?

Evans rejects the comparison.

Although both companies operate in areas related to biological testing, he says Hemanthes uses established Raman spectroscopy techniques rather than attempting to recreate Theranos' original technology.

The company's commercial success and technical capabilities remain to be demonstrated.

The Business Lesson

A compelling mission isn't enough. Your technology must deliver measurable results.

Theranos demonstrates the importance of transparency, independent validation, and realistic promises.

For biotech entrepreneurs, building investor confidence means proving that the technology works before making ambitious claims about its potential.

Watch the original interview: https://www.youtube.com/watch?v=2tAywoHiIpo

Disclaimer: This article summarizes statements made during the interview. Evans' claims about the Theranos case and Hemanthes reflect his perspective and have not been independently verified.